Dr Wong is an Associate Professor in Medicine, University of Sydney and Senior Consultant Nephrologist at the Concord Repatriate General Hospital, Sydney, Australia. He is a Clinician researcher with a strong interest in understanding the pathomechanism of kidney fibrosis and has actively promoted the development of both clinical and pre-clinical research in delaying chronic kidney disease progression in IgA nephropathy, diabetic nephropathy, and management of cardiovascular complications associated with CKD. He has served as co-Chair of the Clinical Trials and Translation Research Enabler Committee of the Kolling Institute and the Co-Chair of the Research Group for the Chronic and Complex Medicine Network for Northern Sydney Lower Health District. He was the program Chair of the Nephrology and Transplantation Update Course for the Scientific Program and Education Committee, ANZSN, the Chair of the Education Committee for the Asia Pacific Society of Nephrology. He currently serves as Chair of the Oceania South East Asia Regional Board, International Society of Nephrology.
1 APRIL 2023
Time |
Session |
|
14:15
15:15
|
Liz Lightstone
Chairperson
Imperial College London and Hammersmith HospitalUnited Kingdom
Sydney Tang
Chairperson
The University of Hong KongHong Kong, China
-
STOP-ACEi Study
Sunil Bhandari
Speaker
Hull & East Yorkshire Hospitals NHS Trust United Kingdom
-
Q and A
-
DETERMINANTS OF THE EFFECTS OF SGLT2i ON PROGRESSION OF CKD: FURTHER RESULTS FROM THE EMPA-KIDNEY TRIAL
-
Q and A
-
SPARSENTAN REDUCES PROTEINURIA IN PATIENTS WITH IMMUNOGLOBULIN A NEPHROPATHY (IGAN): INTERIM RESULTS OF THE PROTECT STUDY
-
Q and A
-
RANDOMIZED, DOUBLE-BLIND, CONTROLLED TRIAL OF ARTESUNATE IN PATIENTS WITH ACTIVE LUPUS NEPHRITIS
Jianwen YU
Free Communication
The First Affiliated Hospital of Sun Yat-sen UniversityChina
-
Q and A
Plenary Halls 2 & 3
|
17:00
18:00
|
-
Acid-base and Electrolyte Abnormalities in Kidney Disease
-
Acute Kidney Injury Clinical, Drugs, AKI-CKD Continuum 2
-
Chronic Kidney Disease Complications (CVD, Hypertension, Anemia, BMD, Nutrition, Infection) 3
-
Chronic Kidney Disease Diagnosis, Classification and Progression 2
-
Chronic Kidney Disease, Experimental Models, Biomarkers, Precision Medicine 2
Wenjun Ju
Moderator
wenjunj@med.umich.eduUniversity Of Michigan Medical CenterUnited States
-
Clinical Glomerulonephritis 3
-
Covid-19 and CKD
-
Curriculum
-
Diabetic Kidney Disease, Drugs and Treatments 2
-
Epidemiology, Outcomes and Health Service Research Related to CKD or Its Complications 2
Sabine Karam
Moderator
Saint George Hospital University Medical CenterLebanon
-
Epidemiology, Outcomes and Health Services Research in Dialysis 2
-
Essential Hypertension and Renovascular Kidney Disease
Barry Freedman
Moderator
Wake Forest University School of Medicine United States
-
Genetics and Epigenetics (Including Common and Rare Genetic Diseases)
Chairat Shayakul
Moderator
Faculty of Medicine Siriraj Hospital, THAILANDThailand
-
Haemodialysis, Haemodiafiltration and Vascular Access 2
-
Haemodialysis, Haemodiafiltration and Vascular Access 3
Jonathan Himmelfarb
Moderator
jhimmelfarb@nephrology.washington.eduKidney Research Institute, University of Washington United States
-
Inflammation, Fibrosis, Matrix Biology and Oxidative Stress
Youhua LIU
Moderator
University of PittsburghUnited States
-
Kidney Transplantation and Transplant Immunology 3
Narayan Prasad
Moderator
Sanjay Gandhi Post Graduate Institute of Medical SIndia
-
Kidney Transplantation and Transplant Immunology 4
-
Late Breaking Clinical Trials
-
Nephrotic Syndrome
-
Other CKD 2
Jie Dong
Moderator
jie.dong@bjmu.edu.cnPeking University First HospitalChina
-
Other KF (Kidney Failure)
Tai Shuan Lai
Moderator
National Taiwan University HospitalTaiwan
-
Peritoneal Dialysis 2
-
Peritoneal Dialysis 3
-
Training
-
Tropical Kidney Diseases (Viral Nephropathies, TB, Schistosomiasis, Malaria, Leptospirosis, Animal Venoms)
-
Urologic Disorders
-
Vascular Biology and Endothelial Function
Reiko Inagi
Moderator
Univ of Tokyo - Grad. School of MedicineJapan
Ballroom 2-3-4-Exhibition Hall
|
2 APRIL 2023
Time |
Session |
|
08:30
10:00
|
-
CKD with Diabetes vs. Diabetic Nephropathy
-
Treatment 1 (SGLT2, GLP1)
-
Treatment 2 (Finrenone, etc.)
-
Prevention of DKD
Juliana Chan
Speaker
The Chinese University of Hong KongHong Kong, China
-
Q and A
Plenary Hall 1
|
INDUSTRY SYMPOSIA PROGRAM (FRIDAY, MARCH 31, 2023)
Time |
Session |
|
13:00
14:00
|
Organized by Travere Therapeutics
MR 109 ABFE
|